opioids

Abstract Addiction neuroscience models posit that recurrent drug use increases reactivity to drug-related cues and blunts responsiveness to natural rewards, propelling a cycle of hedonic dysregulation that drives addictive behavior. Here...

Source: Silva, T.C., Andersson, F.B. The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence. Subst Abuse Treat Prev Policy 16, 41 (2021). https://doi.org/10.1186/s13011-021...

Abstract Over the past two decades, the National Drug Abuse Treatment Clinical Trials Network (CTN), a program of the National Institute on Drug Abuse (NIDA), has expanded from the initial six Nodes to 16 Nodes, as a nationwide consortium...

This infographic shows the different types of medications prescribed for opioid overdose, withdrawal, and addiction. Medications for opioid addiction, overdose, and withdrawal work in various ways. Opioid Receptor Agonist: Medications...

Source: Naji, L., Rosic, T., Sanger, N., Dennis, B., Worster, A., Paul, J., ... & Samaan, Z. (2020). The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder. Journal of addiction medicine. Abstract Objectives...

Abstract Importance The rapid increase of opioid-related overdoses and deaths has become a public health concern in the US. Use of prescription opioids in pregnant women has increased; results from teratogenicity studies remain...

Abstract Importance: The United States is experiencing a crisis of opioid overdose. In response, the US Department of Health and Human Services has defined a goal to reduce overdose mortality by 40% by 2022. Objective: To identify specific...

Abstract The COVID-19 pandemic resulted in stay-at-home orders, which presented a significant challenge to the design and operation of an essential harm-reduction strategy in the opioid epidemic: community-based, take-home naloxone (THN)...

Abstract Background Improving access to medications for opioid use disorder (MOUD) is a national priority; however, these efforts commonly focus on the provider. Access to buprenorphine through retail pharmacies and stigma associated with...